DNA Repair Gene Expression and Risk of Locoregional Relapse in Breast Cancer Patients

Overexpression of RAD51, a key component of the homologous DNA repair pathway, is associated with poor breast cancer outcome. This finding warrants prospective studies of RAD51 as a prognosticator and therapeutic target.